When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Kaposi's sarcoma

Evidencia revisada por última vez: 2 Apr 2026
Tema actualizado por última vez: 05 Dec 2025

Resumen

Definición

Anamnesis y examen

Principales factores de diagnóstico

  • presence of risk factors
  • age >50 years
  • male sex
  • geographical location: central Africa or the Mediterranean
  • HIV infection
  • human herpesvirus-8 (HHV-8, also known as Kaposi's sarcoma-associated herpesvirus [KSHV]) infection
  • immunosuppression
  • skin lesion
  • oral lesion
  • lymphadenopathy
  • lymphoedema
Todos los datos

Otros factores de diagnóstico

  • weight loss
  • abdominal pain
  • gastrointestinal (GI) bleeding
  • diarrhoea
  • dyspnoea
  • haemoptysis
  • chest pain
  • fever
Todos los datos

Factores de riesgo

  • male sex
  • HIV infection
  • immunosuppressive therapy
  • human herpesvirus-8 (HHV-8, also known as Kaposi's sarcoma-associated herpesvirus [KSHV]) infection
  • central African ethnicity
  • drug abuse
  • Jewish ethnicity
  • Mediterranean ethnicity
  • age <5 years or >50 years
  • men who have sex with men
  • Black American ethnicity
Todos los datos

Pruebas diagnósticas

Primeras pruebas diagnósticas para solicitar

  • HIV test
  • FBC and comprehensive metabolic panel
  • skin/mucosal biopsy
Todos los datos

Pruebas diagnósticas que deben considerarse

  • chest x-ray
  • chest CT and bronchoscopy
  • CT abdomen/pelvis
  • MRI
  • faecal occult blood
  • gastrointestinal (GI) endoscopy
  • PET scan
  • lymph node biopsy
  • renal function tests
  • liver function tests
Todos los datos

Pruebas emergentes

  • human herpesvirus-8 (HHV-8) viraemia and serology

Algoritmo de tratamiento

Agudo

HIV-associated KS

classic (sporadic) KS

iatrogenic (transplant-related) KS

endemic (observed in sub-Saharan Africa) KS

Colaboradores

Autores

David Aboulafia, MD

Attending Hematologist and Oncologist

Virginia Mason Clinical Professor of Medicine

Division of Hematology and Oncology

University of Washington

Seattle

WA

Divulgaciones

DA is the author of articles cited in this topic.

Agradecimientos

Dr David Aboulafia would like to gratefully acknowledge Dr Liron Pantanowitz and Dr Bruce J. Dezube, previous contributors to this topic.

Revisores por pares

Justin Stebbing, MA, MRCP, MRCPath, PhD

Consultant Medical Oncologist/Senior Lecturer

Department of Medical Oncology

Imperial College/Imperial Healthcare NHS Trust

Charing Cross Hospital

London

UK

Divulgaciones

JS declares that he has no competing interests.

Thierry Simonart, MD, PhD

Physician

Department of Dermatology

Erasme University Hospital

Brussels

Belgium

Divulgaciones

TS declares that he has no competing interests.

Agradecimiento de los revisores por pares

Los temas de BMJ Best Practice se actualizan de forma continua de acuerdo con los desarrollos en la evidencia y en las guías. Los revisores por pares listados aquí han revisado el contenido al menos una vez durante la historia del tema.

Divulgaciones

Las afiliaciones y divulgaciones de los revisores por pares se refieren al momento de la revisión.

Referencias

Nuestros equipos internos de evidencia y editoriales colaboran con colaboradores expertos internacionales y revisores pares para garantizar que brindemos acceso a la información más clínicamente relevante posible.

Artículos principales

National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: Kaposi sarcoma [internet publication].Texto completo

Lebbe C, Garbe C, Stratigos AJ, et al; European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO), and the European Organisation for Research and Treatment of Cancer (EORTC). Diagnosis and treatment of Kaposi's sarcoma: European consensus-based interdisciplinary guideline (EDF/EADO/EORTC). Eur J Cancer. 2019 Jun;114:117-27. Resumen

National Institutes of Health, Centers for Disease Control and Prevention, and HIV Medicine Association of the Infectious Diseases Society of America. Panel on Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV. 2025 [internet publication].Texto completo

National Institutes of Health, Centers for Disease Control and Prevention, and HIV Medicine Association of the Infectious Diseases Society of America. US Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. 2025 [internet publication].Texto completo

Artículos de referencia

Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.
  • Kaposi's sarcoma images
  • Diferenciales

    • Bacillary angiomatosis
    • Pyogenic granuloma
    • Dermatofibroma
    Más Diferenciales
  • Guías de práctica clínica

    • Suspected cancer: recognition and referral
    • Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV
    Más Guías de práctica clínica
  • padlock-lockedInicie sesión o suscríbase para acceder a todo el BMJ Best Practice

El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad